AIG
ALXO icon

American International Group’s ALX Oncology ALXO Stock Holding History

American International Group’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,000
Closed -$145K – 127
2024
Q1 		$145K Sell
13,000
-398
-3% -$5.59K ﹤0.01% 2319
2023
Q4 		$199K Buy
13,398
+2,600
+24% +$24.7K ﹤0.01% 2171
2023
Q3 		$51.8K Buy
10,798
+385
+4% +$2.09K ﹤0.01% 2806
2023
Q2 		$78.2K Buy
10,413
+60
+0.6% +$393 ﹤0.01% 2720
2023
Q1 		$46.8K Buy
10,353
+206
+2% +$1.56K ﹤0.01% 2736
2022
Q4 		$114K Sell
10,147
-37
-0.4% -$416 ﹤0.01% 2442
2022
Q3 		$97K Buy
10,184
+144
+1% +$1.68K ﹤0.01% 2573
2022
Q2 		$81K Buy
10,040
+1,237
+14% +$13.5K ﹤0.01% 2704
2022
Q1 		$149K Sell
8,803
-619
-7% -$10.6K ﹤0.01% 2417
2021
Q4 		$202K Sell
9,422
-283
-3% -$12.2K ﹤0.01% 2365
2021
Q3 		$717K Sell
9,705
-230
-2% -$15.3K ﹤0.01% 1625
2021
Q2 		$543 Sell
9,935
-233
-2% -$13.9K ﹤0.01% 1869
2021
Q1 		$750 Buy
10,168
+4,508
+80% +$355K ﹤0.01% 1621
2020
Q4 		$488 Sell
5,660
-64
-1% -$3.85K ﹤0.01% 1758
2020
Q3 		$216K Buy
+5,724
New +$225K ﹤0.01% 2099

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

American International Group's ALXO Position: Q2 2024 in Review

American International Group sold out of ALX Oncology (ALXO) in Q2 2024, closing a stake of 13,000 shares — an estimated $145K sold.

American International Group first reported a position in ALXO in Q3 2020 and held it in 15 quarters. The position peaked at $717K in Q3 2021. 111 funds tracked by Wall St. Rank hold ALXO as of Q2 2024.

  • American International Group reported no remaining ALX Oncology position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 13,000 ALX Oncology shares in Q2 2024, an estimated $145K.
  • American International Group first reported a position in ALX Oncology in Q3 2020 and held it in 15 quarters.
  • American International Group's ALX Oncology position peaked at $717K in Q3 2021.
  • 111 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.